Effects of melatonin and age on gene expression in mouse CNS using microarray analysis

Edward H. Sharman, Stephen C. Bondy, Kaizhi G. Sharman, Debomoy Lahiri, Carl W. Cotman, Victoria M. Perreau

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The expression levels of a number of genes associated with inflammation and immune function change with advancing age. Melatonin modulates gene expression levels of several of these genes. Therefore the declining levels of melatonin associated with age may play a role in the physiological effects of aging. We used oligonucleotide microarrays to measure age-related changes in mRNA expression in the murine CNS, and to study the effect of prolonged administration of dietary melatonin upon these changes. CB6F1 male mice were fed 40 ppm melatonin for 2.1 months prior to sacrifice at age 26.5 months, and compared with both age-matched controls and young, 4.5-month-old untreated controls. Total RNA was extracted from whole brain (excluding cerebellum and brain stem) and individual samples were hybridized to Affymetrix Mouse 430-2.0 arrays. The expression of a substantial number of genes was modulated by melatonin treatment and changes in selected genes were validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR). A subset of these genes did not change with age. Conversely, some genes modulated by age were also modulated by melatonin treatment. In general, melatonin treatment drove the expression levels of these genes closer to the expression levels detected in the younger animals. Notably, the abundance of lipocalin 2 (Lcn2) mRNA increased with age and was decreased in old animals treated with melatonin. Lcn2 is a member of the acute phase response family of proteins and its mRNA levels in the brain increase in response to inflammation. Many of the genes with expression reduced by melatonin are involved in inflammation and the immune system. This suggests that melatonin treatment may influence the inflammatory responses of old animals, driving them to resemble more closely those occurring in young animals.

Original languageEnglish
Pages (from-to)336-344
Number of pages9
JournalNeurochemistry International
Volume50
Issue number2
DOIs
StatePublished - Jan 2007

Fingerprint

Melatonin
Microarray Analysis
Gene Expression
Genes
Inflammation
Messenger RNA
Acute-Phase Reaction
Brain
Oligonucleotide Array Sequence Analysis
Cerebellum
Brain Stem
Reverse Transcription
Immune System
RNA
Polymerase Chain Reaction

Keywords

  • Aging
  • Brain
  • Diet
  • Immunity
  • Melatonin
  • Microarray
  • mRNA

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Effects of melatonin and age on gene expression in mouse CNS using microarray analysis. / Sharman, Edward H.; Bondy, Stephen C.; Sharman, Kaizhi G.; Lahiri, Debomoy; Cotman, Carl W.; Perreau, Victoria M.

In: Neurochemistry International, Vol. 50, No. 2, 01.2007, p. 336-344.

Research output: Contribution to journalArticle

Sharman, Edward H. ; Bondy, Stephen C. ; Sharman, Kaizhi G. ; Lahiri, Debomoy ; Cotman, Carl W. ; Perreau, Victoria M. / Effects of melatonin and age on gene expression in mouse CNS using microarray analysis. In: Neurochemistry International. 2007 ; Vol. 50, No. 2. pp. 336-344.
@article{44d699a26d7244bab0e5894568f14e1a,
title = "Effects of melatonin and age on gene expression in mouse CNS using microarray analysis",
abstract = "The expression levels of a number of genes associated with inflammation and immune function change with advancing age. Melatonin modulates gene expression levels of several of these genes. Therefore the declining levels of melatonin associated with age may play a role in the physiological effects of aging. We used oligonucleotide microarrays to measure age-related changes in mRNA expression in the murine CNS, and to study the effect of prolonged administration of dietary melatonin upon these changes. CB6F1 male mice were fed 40 ppm melatonin for 2.1 months prior to sacrifice at age 26.5 months, and compared with both age-matched controls and young, 4.5-month-old untreated controls. Total RNA was extracted from whole brain (excluding cerebellum and brain stem) and individual samples were hybridized to Affymetrix Mouse 430-2.0 arrays. The expression of a substantial number of genes was modulated by melatonin treatment and changes in selected genes were validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR). A subset of these genes did not change with age. Conversely, some genes modulated by age were also modulated by melatonin treatment. In general, melatonin treatment drove the expression levels of these genes closer to the expression levels detected in the younger animals. Notably, the abundance of lipocalin 2 (Lcn2) mRNA increased with age and was decreased in old animals treated with melatonin. Lcn2 is a member of the acute phase response family of proteins and its mRNA levels in the brain increase in response to inflammation. Many of the genes with expression reduced by melatonin are involved in inflammation and the immune system. This suggests that melatonin treatment may influence the inflammatory responses of old animals, driving them to resemble more closely those occurring in young animals.",
keywords = "Aging, Brain, Diet, Immunity, Melatonin, Microarray, mRNA",
author = "Sharman, {Edward H.} and Bondy, {Stephen C.} and Sharman, {Kaizhi G.} and Debomoy Lahiri and Cotman, {Carl W.} and Perreau, {Victoria M.}",
year = "2007",
month = "1",
doi = "10.1016/j.neuint.2006.09.001",
language = "English",
volume = "50",
pages = "336--344",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Effects of melatonin and age on gene expression in mouse CNS using microarray analysis

AU - Sharman, Edward H.

AU - Bondy, Stephen C.

AU - Sharman, Kaizhi G.

AU - Lahiri, Debomoy

AU - Cotman, Carl W.

AU - Perreau, Victoria M.

PY - 2007/1

Y1 - 2007/1

N2 - The expression levels of a number of genes associated with inflammation and immune function change with advancing age. Melatonin modulates gene expression levels of several of these genes. Therefore the declining levels of melatonin associated with age may play a role in the physiological effects of aging. We used oligonucleotide microarrays to measure age-related changes in mRNA expression in the murine CNS, and to study the effect of prolonged administration of dietary melatonin upon these changes. CB6F1 male mice were fed 40 ppm melatonin for 2.1 months prior to sacrifice at age 26.5 months, and compared with both age-matched controls and young, 4.5-month-old untreated controls. Total RNA was extracted from whole brain (excluding cerebellum and brain stem) and individual samples were hybridized to Affymetrix Mouse 430-2.0 arrays. The expression of a substantial number of genes was modulated by melatonin treatment and changes in selected genes were validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR). A subset of these genes did not change with age. Conversely, some genes modulated by age were also modulated by melatonin treatment. In general, melatonin treatment drove the expression levels of these genes closer to the expression levels detected in the younger animals. Notably, the abundance of lipocalin 2 (Lcn2) mRNA increased with age and was decreased in old animals treated with melatonin. Lcn2 is a member of the acute phase response family of proteins and its mRNA levels in the brain increase in response to inflammation. Many of the genes with expression reduced by melatonin are involved in inflammation and the immune system. This suggests that melatonin treatment may influence the inflammatory responses of old animals, driving them to resemble more closely those occurring in young animals.

AB - The expression levels of a number of genes associated with inflammation and immune function change with advancing age. Melatonin modulates gene expression levels of several of these genes. Therefore the declining levels of melatonin associated with age may play a role in the physiological effects of aging. We used oligonucleotide microarrays to measure age-related changes in mRNA expression in the murine CNS, and to study the effect of prolonged administration of dietary melatonin upon these changes. CB6F1 male mice were fed 40 ppm melatonin for 2.1 months prior to sacrifice at age 26.5 months, and compared with both age-matched controls and young, 4.5-month-old untreated controls. Total RNA was extracted from whole brain (excluding cerebellum and brain stem) and individual samples were hybridized to Affymetrix Mouse 430-2.0 arrays. The expression of a substantial number of genes was modulated by melatonin treatment and changes in selected genes were validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR). A subset of these genes did not change with age. Conversely, some genes modulated by age were also modulated by melatonin treatment. In general, melatonin treatment drove the expression levels of these genes closer to the expression levels detected in the younger animals. Notably, the abundance of lipocalin 2 (Lcn2) mRNA increased with age and was decreased in old animals treated with melatonin. Lcn2 is a member of the acute phase response family of proteins and its mRNA levels in the brain increase in response to inflammation. Many of the genes with expression reduced by melatonin are involved in inflammation and the immune system. This suggests that melatonin treatment may influence the inflammatory responses of old animals, driving them to resemble more closely those occurring in young animals.

KW - Aging

KW - Brain

KW - Diet

KW - Immunity

KW - Melatonin

KW - Microarray

KW - mRNA

UR - http://www.scopus.com/inward/record.url?scp=33846228446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846228446&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2006.09.001

DO - 10.1016/j.neuint.2006.09.001

M3 - Article

C2 - 17118492

AN - SCOPUS:33846228446

VL - 50

SP - 336

EP - 344

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 2

ER -